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Abstract 
Less than optimal particle isolation techniques have impeded analysis of orthopaedic 
wear debris in vivo. The purpose of this research was to develop and test an 
improved method for particle isolation from tissue. A volume of 0.018 mm3 of 
clinically relevant CoCrMo, Ti-6Al-4V or Si3N4 particles was injected into rat stifle 
joints for seven days of in vivo exposure. Following sacrifice, particles were located 
within tissues using histology. The particles were recovered by enzymatic digestion 
of periarticular tissue with papain and proteinase K, followed by ultracentrifugation 
using a sodium polytungstate density gradient. Particles were recovered from all 
samples, observed using SEM and the particle composition was verified using EDX, 
which demonstrated that all isolated particles were free from contamination. Particle 
size, aspect ratio and circularity were measured using image analysis software. 
There were no significant changes to the measured parameters of CoCrMo or Si3N4 
particles before and after the recovery process (KS tests, p>0.05).  Titanium particles 
were too few before and after isolation to analyse statistically, though size and 
morphologies were similar. Overall the method demonstrated a significant 
improvement to current particle isolation methods from tissue in terms of sensitivity 
and efficacy at removal of protein, and has the potential to be used for the isolation 
of ultra-low wearing total joint replacement materials from periprosthetic tissues. 
Keywords: 
Silicon nitride, cobalt chromium, titanium, particle isolation, wear, total joint replacement 
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1 Introduction 
Adverse tissue reactions to wear debris, which may lead to aseptic loosening, are 
one of the most common causes of total hip replacement (THR) revision [1]. Aseptic 
loosening remains the most cited reason for THR revision, accounting for 51% of 
single-stage revisions, while adverse reactions to particulate wear debris account for 
10.8% of single-stage revisions [1]. However, the extent of adverse reactions to wear 
debris is likely to be underestimated, as this was not an option on the revision report 
forms in the early phase of the National Joint Registry. Several reasons for revision 
are often given and categories are not mutually exclusive; aseptic loosening and 
other cited reasons including pain (22.0% of single-stage THR revisions) and lysis 
(15.6%) are often the result of reactions to wear debris [2, 3]. Device failure may be 
due to a combination of mechanical failure, resulting in high wear, and adverse 
responses to the wear particles, due to use of potentially unsafe materials. 
Assessing the biocompatibility of wear debris is therefore crucial to preventing 
unsafe devices, such as several recalled metal-on-metal THRs, from reaching the 
market [4]. This is reflected in the publication of recent FDA guidelines [5] for the 
biological evaluation of medical devices, which requests the preclinical assessment 
of wear debris, including geometric and/or physicochemical properties, specifically in 
relation to potential biological hazards due to mechanical failure, such as excess 
wear debris produced as a result of coating delamination. It is thus likely that there 
will be an increased interest in analysis of wear particles, which may require the use 
of particle isolation techniques from serum, synovial fluid or tissue. 
Particle isolation and subsequent characterisation requires removal of protein and 
other contaminants such as lipids [6]. Treatment using strong acids or bases has 
been effectively used to solubilise tissue and facilitate particle extractions. Such 
protocols have included sodium hydroxide [7-11], potassium hydroxide [12-14] and 
nitric acid [15-17]. The acids or bases were used at high concentrations from 4 M to 
12 M and for one to five days for formalin-fixed tissue, most often at 65°C. Other 
studies have isolated metal and ceramic particles using mixed enzymatic and 
acid/base digestion [18-20]. Although chemical treatment using acids or bases is 
more efficient than enzymatic tissue digestion [21], acids and bases damage metal 
particles [22], and thus have been predominantly used to isolate polyethylene 
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particles. Previous studies have used papain and proteinase K to digest 
periprosthetic tissue to isolate metal particles, with subsequent centrifugation to 
remove proteins [23], a method which was used and adapted in several later studies 
for either serum or tissue digestion [22, 24, 25]. However, such methods involved 
high temperature stages such as boiling samples in sodium dodecyl sulphate (SDS), 
which may be overly destructive to recent orthopaedic materials such as silicon 
nitride (Si3N4), which has dissolution properties. Furthermore, the method detailed in 
the ISO standard for metal particle isolation from tissue [26] requires the use of a 
tissue homogeniser which could affect large particles and employs multiple washes 
at relatively low centrifugation speeds of 16,000 RCF (relative centrifugal force) for 
only ten minutes, which could be insufficient to sediment certain particles. The 
method could therefore lead to particle loss, making it unsuitable for the recovery of 
low particle volumes. Due to such disadvantages, particle isolation is not always 
performed in practice. Further drawbacks of previous methods have included the 
need for expensive equipment and the length of time required to perform the 
experiments, a lack of any demonstrated technique sensitivity (as defined by the 
minimum initial volume of particles that could be successfully extracted from a tissue 
sample), unsatisfactory results due to protein or bacterial contamination or the 
presence of extraneous impurities. Many of the methods also did not establish 
whether use of the isolation method caused any significant changes to particle 
measurements.  
Although several recent publications have provided updated methods for isolating 
low-wearing materials from serum with proven sensitivity [27, 28], such studies have 
not considered the isolation of particles from tissue, which can be useful when 
performed on periprosthetic tissue from around explants for diagnostic purposes. 
The method described by [28] to isolate Si3N4 particles from wear simulator serum 
using density gradient ultracentrifugation with novel sodium polytungstate gradients 
demonstrated no detectable particle loss at key stages of the procedure, and no 
detectable changes to particle size or morphology. The method is relatively quick to 
perform (the protocol requires approximately four days), is cost effective and does 
not require specialist equipment, making it an attractive technique.  
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The overall aim of this research study was to produce an improved method for the 
isolation of wear particles from tissue, using enzymatic digestion and sodium 
polytungstate density gradients, and test the method in a small animal model on a 
range of materials.  
2 Materials and Methods 
2.1 Details of the particles employed in the study 
Three clinically relevant materials were used in this study: silicon nitride (Si3N4), a 
ceramic material which has been used as an orthopaedic bearing material in cervical 
spacers and spinal fusion devices and which is currently being investigated as a 
potential joint replacement coating, cobalt chromium molybdenum alloy (CoCrMo) 
and titanium aluminium vanadium alloy (Ti-6Al-4V), both of which have been used 
extensively in various orthopaedic devices for several decades and are included 
here as intended substrate materials for the Si3N4 coating. The Si3N4 particles used 
were a commercially available nanopowder (<50 nm, Sigma-Aldrich). Wear debris of 
CoCrMo and Ti-6Al-4V were generated using a six-station multidirectional pin-on-
plate wear simulator using sterile filtered water as a lubricant, as described 
previously [29]. Aliquots of each of the three particle types were inspected by 
scanning electron microscopy (SEM) prior to use to ensure that no contamination 
was present and that the particles were of a clinically relevant size range. Particles 
were thereafter sterilised by heat treatment at 180 °C for 4 h and sterile stock 
suspensions of 0.9 mm3.ml-1 of each particle type in phosphate buffered saline were 
produced. Prior to immediate use, the particle suspensions were vortexed and 
sonicated for 20 minutes three times to ensure a homogenous dispersion of 
particles.  
2.2 Animal model 
The animal test system used for this study consisted of male Wistar rats, 8-12 weeks 
old and with weights ranging from 297-342 grams. Guidelines contained in EU 
Directive 2010/63/EU for animal experiments were followed [30], and the 
experiments were authorized by the ethical committee under the licence number 
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133/2014. The study involved a total of 18 rats, consisting of three material groups 
(Table 1). Tail marks and subcutaneous transponders were placed on the rats on 
arrival into the facility and the health of each rat was closely monitored; animals with 
any visible signs of illness were excluded from the study. The rats were acclimatised 
for at least eight days prior to the study. Stifle joints were chosen for treatment to 
allow more accuracy and repeatability compared to injection of the hip joints. Rats 
were injected in the right stifle joint using a glass Hamilton syringe (23 gauge) with 
20 µL of a particle suspension (Si3N4, CoCrMo or Ti-6Al-4V), which equated to a 
dose of 0.018 mm3 of particles per rat stifle joint. The left stifle joints were not 
injected and were instead used as untreated control joints. Thereafter rats were 
monitored daily over a seven day period, at which point animals were euthanised 
with a rising CO2 concentration. Excess muscle tissue was removed from the stifle 
joints taking care not to open the joint compartment. The intact rat stifle joints (both 
treated and non-treated) were excised, formalin-fixed for a period of 48 h, and stored 
in 70% (v/v) ethanol. 
Table 1. Particles used for injection into rat stifle joints.  
Material group* Details 
Si3N4  Commercially available nanopowder 
(<50nm, Sigma-Aldrich, UK) 
CoCrMo 
(high carbon; >0.2 %, [31]) 
Particles generated by pin-on-plate in house 
Ti-6Al-4V Particles generated by pin-on-plate in house 
 *Volume of particles injected was 0.018 mm3 and particles were in vivo for a period 
of seven days for each material group (N=6) 
2.3 Histological analysis of rat stifle joints 
Intact stifle joints from three rats from each group were decalcified over five weeks at 
37 °C with agitation using concentrated EDTA (12.5 % w/v, pH 7), replacing the 
EDTA every two - three days. The decalcified stifle joints were then dehydrated in 
ethanol and infiltrated with paraffin wax using a tissue processor. Stifle joints were 
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embedded whole using large embedding moulds. Serial sections of 5 µm were taken 
from a frontal plane from each sample, adhered to charged glass slides, 
deparaffinised in 100 % xylene and transferred to 100 % ethanol. Sections were then 
rehydrated, stained with haematoxylin and eosin and mounted for observation under 
normal Köhler illumination.  
2.4 Analysis of particles within tissue sections using scanning electron microscopy 
Recut sections were deparaffinised, transferred to 100 % ethanol, dried at room 
temperature, coated with carbon to a thickness of approximately 15 nm, and imaged 
using cold field emission scanning electron microscopy (CFE-SEM; Hitachi SU8230) 
with a backscattered electron detector, at magnifications up to 2,000x. Particles were 
analysed by energy dispersive X-ray analysis (X-Max EDX system, Oxford, UK) to 
confirm the composition of the particles; the analysis was performed at a working 
distance of 15 mm and using a potential of 15 kV. 
2.5 Particle isolation 
The recovery rate of the particle isolation method detailed in [28], which utilised 
sodium polytungstate density gradient ultracentrifugation to isolate particles from 
wear simulator serum, was tested gravimetrically by weighing recovered particles on 
filters as detailed in [32] to verify the efficacy of using sodium polytungstate 
gradients. A novel tissue digestion method was developed and optimised as 
described in [33] to produce an isolation protocol for tissue samples. The protocol 
was validated in each material by recovering particles from particle-doped tissue 
samples as detailed in [34] prior to commencing with particle isolation from the 
injected rat stifle joints. 
The remaining three injected stifle joints from each material group, in addition to an 
untreated contralateral stifle joint were washed three times by filling each sample 
tube with sterile filtered water and discarding each wash, and approx. 0.15 g (wet 
weight) of tissues from the ligament of the patella and fat pad were harvested and 
minced. Samples were digested with gentle agitation at 50 ºC with 1.56 mg.mL-1 of 
buffered papain (Sigma-Aldrich, UK), in the presence of 0.1 M HEPES buffer (pH 
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7.5) and 0.33 M glycine (Sigma-Aldrich, UK), in a sample volume of 3 mL (made up 
with sterile water). After six hours of digestion at 50 °C, proteinase K stock solution 
(20 mg.mL-1 in 0.5 M HEPES buffer, pH 7.5, containing 3 mM CaCl2) was added to a 
concentration of 1 mg.mL-1 and SDS was added to a concentration of 0.5% (v/v). 
Digestion was continued at 50 ºC with agitation for 16-20 h, after which an additional 
150 µL of the 20 mg.mL-1 proteinase K stock was added. The addition of 150 µL of 
proteinase k stock was repeated after six hours. Digestion was completed at 48 h. 
Digested samples were subjected to density gradient ultracentrifugation on gradients 
of 2 g.mL-1, 1.6 g.mL-1 and 1.2 g.mL-1 of sodium polytungstate solution; samples 
were ultracentrifuged at an average RCF of 202,048 for 4 h. The supernatant was 
removed from each sample, leaving particles at the bottom of each tube. Addition of 
filtered water and further ultracentrifugation for 1 h at an average RCF of 154,693 
was repeated three times to remove residual SPT. The supernatant was removed 
from each sample, leaving isolated particles which were collected from the bottom of 
each tube. Isolated particle samples were sealed with parafilm and stored at -20 °C, 
before resuspension and filtration for characterisation.  
2.6 Particle characterisation  
Isolated particles (entire samples) were resuspended by sonication in an ice-cooled 
water bath for 20 minutes, vortexing samples every 5 minutes, and filtered onto 
0.015 µm pore size polycarbonate filter membranes. In addition, non-isolated 
particles, which were not injected and thus not subjected to the isolation process, 
were also resuspended filtered for comparison, at volumes of 0.018 mm3. The filters 
were dried overnight at room temperature and mounted directly onto aluminium 
stubs before being coated with iridium to a thickness of 4 nm (Agar Scientific, UK). 
The filter membranes were then imaged using cold field emission (CFE) SEM 
(Hitachi SU8230). For Si3N4 and CoCrMo particles, images were captured at 2,000 x 
and 20,000 x magnification to provide an overview of the filter membranes and 
particle aggregates. In addition, for Si3N4 and CoCrMo particle characterisation, at 
least five random fields of view of particle aggregates were captured at 100,000 x 
magnification for particle characterisation. For titanium particles, due to the large 
particle size range, it was necessary to capture images at magnifications of 100 x, 
500 x and 1,000 x to enable particle characterisation. Elemental characterisation of 
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the particles was performed as detailed in section 2.4, at a magnification of 
approximately 20,000 x. The CFE-SEM micrographs of the particles were 
subsequently analysed using ImageJ (version 1.49), to measure the Feret’s diameter 
(defined as the greatest distance between any two points on the particle boundary), 
aspect ratio (major particle axis / minor particle axis) and circularity (as given by 4π × 
area / [perimeter2]) of the particles. A minimum of 150 Si3N4 and 150 CoCrMo 
particles from each sample were measured in accordance with the standard practice 
for characterisation of particles [26, 35]. A minimum of 100 titanium particles from 
each sample were also measured. 
2.7 Statistics  
Isolated Si3N4 and CoCrMo particles were compared statistically to non-isolated 
particles that were not injected into tissue by Kolmogorov-Smirnov tests of each 
measured parameter (IBM SPSS, v23). In each case, the raw data from 150 isolated 
particles was compared to the raw data from 150 of the non-isolated particles. This 
was repeated for each of the three rat samples using three separate control data 
sets for both material groups. 
3 Results 
3.1 Histological analysis of rat stifle joints 
Particles were not present in non-treated stifle joints and were located toward the 
frontal part of each injected joint. Particles were observed to have formed deposits 
within the fat pad (Figure 1) and were also present in the patella ligament and 
synovium. Silicon nitride particles were barely visible using light microscopy (Figure 
1A), however Ti-6Al-4V and CoCrMo particles were clearly visible and were dark in 
appearance (Figures 1B and 1C). Cellular reactions accompanied the presence of 
particles in all three materials groups, and consisted predominantly of neutrophils, 
macrophages and lymphocytes. A greater response including larger numbers of 
infiltrating cells and possible necrosis, which was completely absent in the other 
material groups, was observed in the CoCrMo group (Figure 1C). 
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3.2 Analysis of particles within tissue sections using scanning electron microscopy 
Analysis of tissue samples using CFE-SEM did not allow cells to be easily 
distinguished, and particles appeared to be partially covered by the extracellular 
matrix; however, particles could be detected within the tissue using back scatter, 
where they appeared bright against a dark background (Figure 2). The CFE-SEM 
analysis of tissue samples showed that the Si3N4 particles were aggregated in a 
similar way to those that were not subjected to in vivo exposure (Figure 2A). Ti-6Al-
4V particles were also similar in appearance to Ti-6Al-4V particles that were not 
subjected to in vivo exposure (Figure 2B). In contrast to CoCrMo particles that were 
directly filtered for CFE-SEM analysis, the CoCrMo particles within tissue sections 
were either present as large deposits (Figure 2C) or dispersed aggregates (Figure 
2D). Elemental analysis confirmed the composition of these particles (Figures 3), 
with silicon and nitrogen present in the Si3N4 group (Figure 3A), titanium and 
aluminium present in the Ti-6Al-4V group (Figure 3B) and cobalt and chromium 
present in the CoCrMo group (Figure 3C). In spectrum analysis, vanadium was also 
identified exclusively in Ti-6Al-4V particles, and molybdenum was identified 
exclusively in CoCrMo particles. CoCrMo particles appeared to be oxidized, as 
significant oxygen signals were detected in the CoCrMo particles (Figure 3C); this 
was not apparent in Si3N4 or Ti-6Al-4V particles. 
3.3 Particle isolation 
The average recovery rate obtained from serum samples doped with 1 mm3 of Si3N4 
particles was 89.6 % +/- 7.1 % SD [32]. Tissue digestion optimisation experiments 
showed that the use of papain, glycine in the buffer, and frequent proteinase K 
enzyme replenishment were required to efficiently digest tissue proteins [33]. 
Validation of the method in tissue samples doped with 2.5 mm3 of particles per 
sample demonstrated that the protocol used had no effect on particle size or 
morphologies for any of the materials, and was effective at very low particle doses 
[34]. 
Digested rat tissue samples were visibly homogeneous, containing no large pieces 
of undigested tissue, and during the isolation process the proteins in each sample 
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formed a faint band within the upper density gradient layers, enabling separation 
from particles. The commercial silicon nitride particles (<50 nm) and titanium 
particles that were used in the study did not form a visible pellet, however CoCrMo 
particles formed a hard pellet following density gradient ultracentrifugation. For each 
material group, particles were isolated from every tissue sample, and were absent 
from the contralateral stifle control sample, demonstrating that particles were not 
present in the tissues as a result of contamination. In every case, isolated particles 
were visibly similar to particles not subjected to the recovery process (Figures 4-6). 
The Si3N4 particles were observed as aggregates of approximately 0.2 - 2 µm in size 
distributed across the filter membrane (Figure 4). Titanium particles were highly 
dispersed on the membrane and showed no aggregation characteristics, in contrast 
to the Si3N4 particles (Figure 5). The CoCrMo particles formed small aggregates of a 
similar size to the Si3N4 aggregates. 
Elemental analysis was used to confirm the composition of the particles post-
isolation (Figure 7), with similar results to those obtained from the elemental analysis 
of tissue sections detailed in section 3.2, as the same elements were present within 
each material (Table 2). The oxidation detected in CoCrMo particles was also 
apparent post-isolation and was also detected to a lesser extent in Si3N4 and Ti-6Al-
4V particles post-isolation (Figure 7C). Furthermore, traces of tungsten were 
detected by spectrum analysis on the CoCrMo particles post-isolation, which likely 
originated from the sodium polytungstate gradient. No other contaminating elements 
were detected. 
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Table 2. Elemental components of particles detected by energy dispersive X-
ray spectroscopy before and after particle isolation. 
 
Elements 
present in 
detectable 
quantities* 
Si3N4 particles Ti-6Al-4V particles CoCrMo particles 
Within 
injected 
rat 
tissue 
After 
isolation 
from 
tissue 
Within 
injected 
rat 
tissue 
After 
isolation 
from 
tissue 
Within 
injected 
rat 
tissue 
After 
isolation 
from 
tissue 
Aluminium 
  X X   
Cobalt 
    X X 
Chromium 
    X X 
Molybdenum 
    X X 
Nitrogen 
X X     
Oxygen 
 X  X X X 
Silicon 
X X     
Titanium 
  X X   
Tungsten 
     X 
Vanadium 
  X X   
*Elements present in the background (such as iridium from the sputter coating) have 
been excluded. Silicon and metal elements were not detected in control tissue from 
an untreated stifle joint. 
Isolated and non-isolated particles had similar size distributions, average particle 
sizes, aspect ratios and circularities (Figure 8). For both Si3N4 and CoCrMo particles, 
sizes ranged from 10-60 nm (Figure 8A and 8B), though the CoCrMo size 
distribution was more positively skewed. Si3N4 particles had a modal particle size of 
20-30 nm, while CoCrMo particles had a modal size of 10-20 nm. Titanium particles 
exhibited a broader size distribution from 0.1 to 100 µm, with a modal particle size of 
10-15 µm (Figure 8C). Based on the measured parameters (Figure 8D), and with 
reference to [35] and [26] the Si3N4 and CoCrMo particles were considered spherical. 
Titanium particles were considered oval or irregular in shape. Statistical analysis of 
the geometric measurements of the Si3N4 and CoCrMo particles confirmed that the 
differences in particle size distributions and morphologies between isolated and non-
isolated particles were not significant (KS test, p>0.05). Titanium particles were not 
analysed statistically, since it was not feasible to measure the minimum of 150 
particles recommended in [26]. 
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4 Discussion 
This study developed novel methodology that successfully isolated low volumes of 
micronscale and nanoscale particles from tissue, without discrimination to particle 
size or morphology, from a total of nine different animal samples. The animals were 
injected with either Si3N4 (N=3), CoCrMo (N=3) or Ti-6Al-4V (N=3), demonstrating 
that the isolation method is effective in a variety of different materials. Initial particle 
volumes were 0.018 mm3, suggesting that the technique is highly sensitive. Particles 
were demonstrably unchanged by the isolation procedure. Proteins were effectively 
removed and the isolated particles were relatively pure, and were not irreversibly 
bound to any surface, so particles isolated using the method have the potential to be 
used in further studies; for example with nanoparticle-tracking analysis. This study 
has taken the initial progress made by [28] forward by adapting the isolation process 
for a new application – the isolation of particles from tissue samples. This has 
involved changes to the method presented by [28] including sample preparation, the 
removal of certain stages of the protocol, and optimisation of the digestion protocol 
specifically for fixed tissue samples. Previously the isolation process had not been 
tested on micron-scale particles, only nanoscale particles, and had also not been 
used to isolate titanium particles. The use of an in vivo model also enabled 
histological analysis of injected particles within tissue sections, scanning electron 
microscopy and elemental analysis of particles within tissues. 
Rats were chosen rather than mice to allow a sufficient dose of particles to be 
injected and to enable an appropriate amount of tissue to be harvested for particle 
isolation; in addition, the joints were still small enough for whole-joint histological 
analysis to be feasible. The volume of injected particles was 0.018 mm3, which is 
lower than the volume of particles that would normally be recovered from an explant 
tissue sample, since the volume of particles per gram of tissue from a failed hip 
prosthesis has been estimated at 0.37 mm3 [36]. Failed ceramic-on-ceramic bearings 
may produce 1-5 mm3 of wear per year [37]. However, particle concentration in any 
given explant tissue sample could vary substantially, for example depending on the 
location from which tissue was extracted, the performance of an implant, and the 
clearance rate of particles within the tissue. Particle amounts could therefore be 
extremely low, especially in well-functioning ceramic-on-ceramic bearings which may 
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produce less than 0.5 mm3 of wear per year in vivo [38]. The current method was 
therefore tested in particle-doped tissue samples at starting volumes as low as 
0.0025 mm3 per sample of tissue [34]. The in vivo exposure time of seven days was 
the maximum time point that could enable protein binding to particles before a large 
volume of particles would be lost through dissemination. It has previously been 
shown that following injection of mice stifle joints with nanoscale and micron scale 
CoCrMo particles, approximately 60 - 70 % of the injected metal was no longer 
present in the peri-articular tissue after seven days, and particles were found to 
disseminate via lymph nodes [39]. Samples in this study were formalin-fixed as this 
is the conventional way to preserve explant samples for biological analysis; 
subsequent storage of samples in 70% (v/v) ethanol also prevents bacterial 
contamination of samples. Particles were first located within histological tissue 
sections with a previously used technique [40] to enable accurate tissue harvesting. 
Due to the small amount of tissue available from a rat stifle joint, initial tissue masses 
(wet weight) were 150 mg; however, since larger quantities of tissue are sometimes 
available from human explant samples, the particle isolation method was also tested 
on initial tissue masses of 250 mg [34]. 
Improvements to the isolation method included optimisation of tissue digestion. 
Glycine was used to achieve complete digestion, as previous research has shown it 
improves formalin-fixed tissue digestion with proteinase K, possibly by preventing 
inactivation of the enzyme or protein re-crosslinking, by inactivating the formyl group 
of formaldehyde [41]. The tissue digestion method was optimised prior to application 
to the in vivo study using cadaveric ovine and porcine capsular tissues [33]. The 
results of this analysis support the use of glycine and the use of papain for 
increasing the efficiency of tissue digestion. More frequent enzyme replenishment, 
rather than larger but less frequent doses were also more effective, possibly due to 
gradual loss of enzyme activity. During the particle isolation protocol, transfer of 
samples between tubes was minimised to twice, and any sample tubes were washed 
with sterile filtered water three times, whilst sonicating, and these washes were 
added to samples, to prevent particle loss. Previous work has shown minimal particle 
loss during removal of supernatant following ultracentrifugation [28], and low speed 
centrifugation steps, which could lead to particle loss, were omitted from the current 
protocol. It is also worth noting that this method required only four days of processing 
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time (excluding particle characterisation), did not require any specialist equipment, 
had relatively few stages and was cost effective, making it more efficient to perform 
then previous methods [24, 42]. Since the particle recovery rate of the method would 
be difficult to accurately assess using an in vivo model due to particle dissemination, 
the recovery rate in particle-doped serum samples was investigated prior to this 
study gravimetrically [32], and an average recovery rate of 89.6 % +/- 7.1 % (SD) 
was achieved. This is a similar recovery rate to that reported by [28]. To prevent 
extraneous particle contamination, where possible all solutions were filtered using 
0.02 µm pore-size filters prior to use. To minimise variations in particle aggregation, 
all particle samples were re-suspended and filtered using the same protocol and to 
prevent bias during imageJ measurements, images were randomised, and all the 
particles that were visible in each image were measured. Manual sizing of individual 
particles was used rather than automatic sizing functions, which may inaccurately 
define particle boundaries. Scanning electron microscopy (SEM) was chosen rather 
than transmission electron microscopy (TEM) for particle characterisation to enable 
the surface characteristics of particles to be analysed. Surface characteristics play a 
crucial role in how particles interact with proteins and thus in the overall 
biocompatibility of a material [43].  
The CoCrMo and Ti-6Al-4V particles used in this study were similar in size and 
shape to those retrieved from periprosthetic tissues and those generated by 
physiological hip simulators [19, 24, 44-46]. The size and shape of CoCrMo and Ti-
6Al-4V particles showed slight variation between the validation study [34] and the rat 
study. In particular, CoCrMo particles were slightly smaller in the rat study and Ti-
6Al-4V particles had a higher average circularity. This may be due to variation 
between particle generation experiments. The model Si3N4 particles used were 
similar in size to recently published data on nanoscale Si3N4 debris produced by a 
coating applied to a CoCrMo substrate [47], though particles up to a few microns in 
size were also identified by [47]. The nanoscale silicon nitride particles were also 
spherical and existed as aggregates of a similar size to those observed in the current 
study. Measuring the chosen parameters for the particles was important due to their 
significance to the biological activity of particles. For example, UHMWPE particles in 
the 0.1 – 1 μm size range have been found to be more biologically active in terms of 
osteolytic cytokine release than particles above 1 µm in size, and it was found that 
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particles of a size below approximately 50 nm failed to elicit a pro-inflammatory 
response in primary cells [48]. Further, based on a murine model involving injected 
particles, nanoscale and not micronscale CoCrMo particles were genotoxic at 40 
weeks in vivo [39]. Size-related differences in particle biocompatibility may be due to 
how readily cells are able to phagocytose particles. Aspect ratio may also affect 
cellular uptake of particles [49], and UHMWPE particles with a more elongated 
shape are more inflammatory [50]. Spherical nanoparticles with a circularity of 
greater than 0.7, when taken up by cells, may have different biological effects than 
less spherical particles, since particles with rough edges may break through 
endosomal or lysosomal membranes and thus reside more frequently in cytoplasm 
[51]. Measuring particle parameters also allows detection of particle dissolution; our 
results suggest that Si3N4 particles may dissolve less quickly in vivo than has been 
previously suggested by simulations of in vivo conditions [47], since there were no 
detectable changes to particle size or shape. Additionally, results suggest that 
corrosion of particles, which may occur within macrophages, did not affect a 
significant number of particles within the given time frame. 
There were several limitations to the current study. Particle adhesion to the glass 
syringe may have occurred during injection, and hence there may have been slightly 
lower actual volumes of particles delivered intra-articularly. Since particles were in 
vivo for a period of seven days, and were introduced via an injection, particles 
produced by a prosthesis may have differing particle aggregation and protein corona 
characteristics, though it has been suggested that a hard protein corona is formed 
after just 48 h [52]. In addition, particles may not have dispersed as they would in an 
in vivo scenario where particles are continuously produced. It is also possible that 
there were subtle changes to particle geometries that could not be detected due to 
the resolution limit of the SEM equipment; however, international guidelines for 
minimum magnifications were followed [26, 35]. The measurements of the particles 
were also limited due to their aggregated nature, which meant that manual particle 
sizing was required. This limited the number of particles that it was feasible to size, 
though international guidelines were also followed with regard to minimum particle 
numbers for statistical analysis of particle characteristics. Another possible limitation 
of the current study is that during elemental analysis of isolated particles, tungsten 
was identified on CoCrMo particles. However, this had no detectable effect on 
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particle size or morphology and the tungsten could likely be removed by further 
rounds of ultracentrifugation, as described in the washing stages of the protocol. 
Furthermore, elemental analysis demonstrated a lack of any other contaminating 
elements on particles, suggesting that particles were relatively pure. 
5 Conclusion 
The isolation technique reported here represents an improvement to current particle 
isolation methods from tissue, due to its more effective removal of proteins and 
greater sensitivity. This work could be valuable to future animal and explant studies 
evaluating ceramic or metal particles, especially as the latest generation of 
orthopaedic materials are highly wear-resistant, and thus there may be a need to 
isolate increasingly lower volumes of particles.  
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Figure 1. Histological sections from (A) a Si3N4 injected rat stifle joint, (B) a Ti-
6Al-4V injected joint, and (C) a CoCrMo injected joint. The joints were embedded 
in paraffin wax whole, cut from a frontal plane, stained with H&E and viewed under 
normal Köhler illumination. Areas of inflammation and particle deposition in the fat 
pad are shown in high magnification beneath; particles are indicated by red arrows 
and specific cell types are labelled with black arrows. 
P = patella, FC = femoral condyle, L = ligament, Ly = lymphocyte, M = macrophage, 
N = neutrophil, T = tibia 
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Figure 2. Images of a whole joint section from (A) a Si3N4 injected rat stifle 
joint, (B) a Ti-6Al-4V injected joint and (C) and (D), a CoCrMo injected joint. The 
tissue sections were dehydrated in ethanol, carbon coated and imaged by scanning 
electron microscopy using back scattered electrons, to enable heavier elements to 
be distinguished by their brighter appearance. Particle aggregates are indicated by 
red arrows. 
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Figure 3. Elemental analysis of tissue sections from (A) a Si3N4 injected rat 
stifle joint, (B) a Ti-6Al-4V injected joint, and (C) a CoCrMo injected joint. The 
sections were dehydrated in ethanol, carbon coated and imaged by scanning 
electron microscopy with back scattered electrons (grayscale images); elements 
were detected by energy dispersive X-ray spectroscopy to produce corresponding 
elemental maps of each imaged area (coloured images). Carbon, oxygen and 
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nitrogen were ubiquitous in the tissue. Signals originating from the glass slide were 
omitted. 
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Figure 4. Si3N4 particles imaged by scanning electron microscopy. (A) Particles 
not injected or subjected to the recovery procedure, at a low magnification. (B) 
Particles following isolation from an injected rat stifle joint, at the seven-day in vivo 
time point, at a low magnification. (C) The same particles as (A) at a high 
magnification. (D) The same particles as (B) at a high magnification. 
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Figure 5. Ti-6Al-4V particles imaged by scanning electron microscopy. (A) 
Particles not injected or subjected to the recovery procedure, at a low magnification. 
(B) Particles following isolation from an injected rat stifle joint, at the seven-day in 
vivo time point, at a low magnification. (C) The same particles as (A), at a high 
magnification. (D) The same particles as (B) at a high magnification. 
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Figure 6. CoCrMo particles imaged by scanning electron microscopy. (A) 
Particles not injected or subjected to the recovery procedure, at a low magnification. 
(B) Particles following isolation from an injected rat stifle joint, at the seven-day in 
vivo time point, at a low magnification. (C) The same particles as (A) at a high 
magnification. (D) The same particles as (B) at a high magnification. 
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Figure 7. Elemental analysis of particles isolated from (A) a Si3N4 injected rat 
stifle joint, (B) a Ti-6Al-4V injected joint and (C) a CoCrMo injected joint. The 
isolated particles were filtered directly onto polycarbonate membranes, iridium 
coated and imaged by scanning electron microscopy with back scattered electrons 
(grayscale images); elements were detected by energy dispersive X-ray 
spectroscopy to produce corresponding elemental maps of each imaged area 
(coloured images). Carbon signals originated from the polycarbonate membrane. 
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Figure 8. Size distributions and average particle measurements for pristine, non-
isolated particles, and particles isolated from injected rat stifle joints, for (A) 
Si3N4 (B) Ti-6Al-4V and (C) CoCrMo material groups, and (D) average particle 
parameters for each material. Error bars give standard deviation (+/-). 
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Statement of Significance 
 
This research presents a novel method for the isolation of wear particles from tissue. 
Methodology outlined in this work would be a valuable resource for future 
researchers wishing to isolate particles from tissues, either as part of preclinical 
testing, or from explants from patients for diagnostic purposes. It is increasingly 
recognised that analysis of wear particles is critical to evaluating the safety of an 
orthopaedic device. 
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